Related Experiment Video
Updated: May 2, 2026

Establishment of the Dual Humanized TK-NOG Mouse Model for HIV-associated Liver Pathogenesis
Published on: September 11, 2019
Barriers to liver transplantation in HIV infected patients
C Wyndham-Thomas1, M Delforge2, J P Mulkay2
1Division of Infectious disease, CHU Saint Pierre, Université Libre de Bruxelles, Brussels, Belgium. cwyndham@ulb.ac.be
Insights
Barriers limit liver transplantation for HIV patients with liver disease, with few meeting criteria for listing. Early referral and awareness are crucial for successful outcomes in this population.
Area of Science:
- Hepatology
- Infectious Diseases
- Transplantation Medicine
Background:
- Liver disease is a leading cause of non-AIDS mortality in HIV patients.
- Liver transplantation offers a therapeutic option for advanced liver disease in HIV patients.
- Limited data exists on liver transplantation barriers for HIV patients in specific cohorts.
Purpose of the Study:
- To identify barriers to liver transplantation in HIV patients within the Brussels Saint-Pierre HIV Cohort.
- To analyze reasons for patient exclusion from liver transplant candidacy.
- To assess the impact of HIV and non-HIV related factors on transplant eligibility.
Main Methods:
- Retrospective review of HIV patients with a theoretical indication for liver transplantation (01/01/2002-01/07/2010).
- Classification of reasons for not being listed as candidates (HIV-related, non-HIV related, multifactorial).
- Analysis of patient demographics, co-infections (HBV/HCV), and reasons for non-candidacy.
Main Results:
- Nineteen patients with HBV and/or HCV co-infection were identified.
- Major reasons for non-candidacy included non-adherence, alcohol abuse, psychiatric disease, and hepatotoxicities.
- Only one of three potential candidates was listed, dying before transplant; others chose alternative treatments.
Conclusions:
- Few HIV patients with indications for liver transplantation meet the criteria for enlistment.
- Barriers such as non-adherence, substance abuse, and comorbidities significantly impact candidacy.
- Increased awareness and early referral are essential to improve pre-transplant management and transplant rates for HIV patients with end-stage liver disease.
Objectives:
Liver disease is one of the most frequent causes of non AIDS related deaths in HIV patients and transplantation has become a therapeutic option. In spite of this progress, no liver transplantation has ever been recorded for the patients of the Brussels Saint-Pierre HIV Cohort. The aim of this study is to identify the barriers to liver transplantation in HIV patients that arise in our practice.
Methods:
All patients enrolled in the Brussels Saint-Pierre HIV Cohort presenting a theoretical indication for liver transplantation, as recommended by the AASLD, between 01/01/2002 and 01/07/2010 were considered. The reasons for not retaining these patients as candidates for liver transplantation were classified as HIV or non-HIV related.
Results:
Nineteen patients were identified. All patients presented an HBV and/or HCV co-infection. Indication for liver transplantation was based on first severe complication of cirrhosis for 15 patients, hepatocellular carcinoma fulfilling the Milan criteria for 2 and chronic liver failure for 2 others. Three patients could have been transplantation candidates but only one was enlisted and died prior to transplantation whilst alternative treatments were chosen for the remaining two. Among the non candidates, 5 couldn't be enlisted for HIV-related reasons, 3 for non HIV related reasons and 8 on multifactorial grounds; non adherence to treatment, alcohol abuse, psychiatric disease and hepatotoxicities playing key roles. Eleven patients died, all within 12 months of their first major complication of cirrhosis.
Conclusions:
The undeniable medical progress that liver transplantation represents for HIV-infected individuals is, in practise, limited; only a minority of patients with an indication of liver transplant will fulfill the necessary criteria for enlistment. General awareness of this issue and early referral are essential to optimize pre-transplant management and increase the number of HIV patients developing ESLD that will be able to benefit from this cure.
Related Concept Videos
Kidney Transplant I: Introduction
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Tissue Transplantation
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
Hepatitis
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

